chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Aching of upper body; Headache; Feeling tired; This case was reported by a consumer via call center representative and described the occurrence of general body pain in a 53-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   On 8th February 2021, the patient received the 1st dose of Shingrix (intramuscular). In February 2021, less than 2 weeks after receiving Shingrix, the patient experienced general body pain, headache and tiredness. On an unknown date, the outcome of the general body pain, headache and tiredness were not recovered/not resolved.   It was unknown if the reporter considered the general body pain, headache and tiredness to be related to Shingrix.  Additional case details were reported as follows: This case was reported by patient herself. The patient received 1st dose of Shingrix in the left deltoid and had aching in the upper body, headache, and was feeling tired. The patient was unsure if it was because of the vaccine or a bug. Her doctor was aware of the side effects and she was awaiting a callback from the nurse. The patient gave permission to follow-up with her HCP, but she did not have HCP's email/fax to provide. The patient consented to follow up.
Hand was tingling and numb like I had slept on it and it is still like that; My fingers on my right hand; Hand was tingling and numb like I had slept on it and it is still like that; My fingers on my right hand; This is a spontaneous report from a contactable consumer or other non hcp (patient). A patient of unspecified age and gender received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; formulation: Solution for injection, Batch/Lot Number: EW0179), via an unspecified route of administration on an unspecified date as DOSE 1, SINGLE for covid-19 immunisation. The patient medical history and concomitant medications were not reported. It was reported that patient was calling because patient took the Pfizer vaccine on the 29th (not clarified) and on the 30th, patient woke up and hand was tingling and numb like, patient had slept on it and it was still like that, today was the 8th. Patient stated that fingers on right hand, was that one of the side effect. Patient wanted to know that how long is it supposed to last. The Outcome of the events was unknown.  No follow-up attempts are needed. No further information is expected.
Zingy headaches persisting behind both ears causing significant sleep deprivation. Lower back pain, swelling and pain at injection sight. Lack of appetite, persistent cough. Basically I am exhibiting all known side affects of the second Moderna dose.
A pharmacist reported the occurrence of fever in a 24-month-old male who was vaccinated with diphtheria and tetanus toxoids and acellular pertussis vaccine adsorbed (Infanrix) for prophylaxia. Additional information was received from the pt's father. The pt's medical history included fever after an unspecified immunization administered at 1 year of age. Concurrent conditions and concurrent medications were not specified. The pt received injections of Infanrix on 01/09/2001, 03/16/2001, 05/17/2001 and 04/18/2002. On 11/12/2002 the pt inadvertently received his 5th injection of Infanrix at the age of 24 months, instead of the recommended age of 4 to 6 years. On 11/12/2002, the pt also received an injection of 7-valent pneumococcal conjugate vaccine (Prevnar, Lederle Labs). According to the pt's father, at an unspecified time post-immunization on 11/12/2002, the pt developed a fever.
Received the vaccine 1/30/2021 and had expected discomfort in right arm. Some swelling, warmth to the touch, painful. Lasted 2 days. In the middle of the night between 2/6/2021 and 2/7/2021 I started experiencing enough pain in my right armpit that woke me up in the middle of the night. I felt that it was likely swollen lymph nodes and took some Advil to relieve the discomfort.  My armpit was sore through the weekend and the discomfort has slowly decreased. Today the area feels slightly swelled and I have experienced some aching in my right breast. It also feels as if my lymph nodes have started to get inflamed in my right groin area (2/8/2021).
WHOLE BODY SORE; SORE JOINTS; HEADACHE (FRONT, EYES, BEHIND THE EYES, AND MIDDLE OF THE HEAD); TIREDNESS; This spontaneous report received from a patient concerned a 58 year old female. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, and batch number: 1808980 expiry: UNKNOWN) dose was not reported, administered on 02-APR-2021 on left arm for prophylactic vaccination. No concomitant medications were reported.  On APR-2021, the subject experienced whole body sore. On APR-2021, the subject experienced sore joints. On APR-2021, the subject experienced headache (front, eyes, behind the eyes, and middle of the head). On APR-2021, the subject experienced tiredness. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from whole body sore, and sore joints on APR-2021, and had not recovered from headache (front, eyes, behind the eyes, and middle of the head), and tiredness. This report was non-serious.
Headache; muscle ache; nausea; This is a spontaneous report from a contactable consumer or other non-hcp (Patient). A 71-year-old non-pregnant female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation solution for injection; Lot Number: EL9266) via an unspecified route of administration in Left Arm on 22Feb2021 02:30 PM as 1st dose single for COVID-19 immunization. Medical history included diabetes mellitus from an unknown date and unknown if ongoing. Concomitant medication included dulaglutide, metformin, atorvastatin and estrogens conjugated taken for an unspecified indication, start and stop date were not reported. The patient does not have allergies. It was reported that the patient has not taken any other vaccine in four weeks. On 23Feb2021 07:00 AM; the patient experienced headache, muscle ache and nausea. The seriousness of the events was reported as non-serious. The clinical outcome of the events was recovered.  No follow-up attempts are possible. No further information expected.
red splotches all over body, genital area-almost like a burn, skin peel bottom of feet, fever 102-103 beginning 15AUG96 thru 17AUG96;tx febrile med x 3 days & steroid ointment;went to clinic;
TACHYCARDIA; SHORTNESS OF BREATH; FATIGUE; FULLNESS AT BASE OF SKULL; HIGH BLOOD PRESSURE; ARM DISCOMFORT; This spontaneous report received from a patient concerned a 54 year old female. The patient's height, and weight were not reported. The patient's past medical history included hysterectomy om hormone replacement, and concurrent conditions included hypothyroidism, and other pre-existing medical conditions included patient had no known allergies. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unk) dose was not reported, administered on 26-MAR-2021 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported.  On 26-MAR-2021, the subject experienced arm discomfort. On 27-MAR-2021, the subject experienced high blood pressure. Laboratory data included: Blood pressure high (NR: not provided) 170/90 mmHg, 175/102 mmHg. On 28-MAR-2021, the subject experienced fullness at base of skull. On 28-MAR-2021, the subject experienced fatigue. On 09-APR-2021, the subject experienced shortness of breath. On 10-APR-2021, the subject experienced tachycardia. On 14-APR-2021, Laboratory data included: CT scan (NR: not provided) Normal, no PE. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from fullness at base of skull, and fatigue on 29-MAR-2021, tachycardia on 14-APR-2021, and arm discomfort on 27-MAR-2021, was recovering from shortness of breath, and had not recovered from high blood pressure. This report was non-serious.
MILD TINGLING SENSATION IN THE ARM; This spontaneous report received from a patient concerned a 50 year old male. The patient's height, and weight were not reported. The patient's concurrent conditions included: non alcoholic, and non smoker. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin, and batch number were not reported) dose was not reported, administered on MAY-2021 for prophylactic vaccination. The batch number was not reported. The company is unable to perform follow up to request batch/lot number. No concomitant medications were reported. On MAY-2021, the patient experienced mild tingling sensation in the arm. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from mild tingling sensation in the arm on MAY-2021. This report was non-serious.
Per report of FNP, pt complained of swelling  of tongue, no acute respiratory distress at 3:16 pm,  pulse 104, O2 Sat 98%. Pt took Benadryl 50 mg. At 03:17 pm pulse 87, O2 Sat 99 %. At 3:27 pm pulse  82, O2 Sat 95 %.  At 3:32 pm pt was instructed  by  FNP to take Epi pen at home and call 911, if there is no improvement. Pt was discharged in stable condition per report of  FNP. RN.
This spontaneous report as received from a medical assistant concerning an unspecified number of patients, of an unknown age and gender. Medical history and concurrent conditions were not reported. On an unknown date the patients were vaccinated with a dose of VAQTA, dose number, lot number, expiration date and route were not reported. Co-suspect and concomitant therapies were not reported. The medical assistant reported that unspecified patients received VAQTA exposed to 49F for 35 minutes, on an unknown date. No adverse effects were reported. This is one (1) of four (4) reports from the same source (MARRS 1408USA016198, 1409USA006389, 1409USA00638 and 1409USA006390. Additional information has been requested.
Fever, severe body aches, swollen lymph nodes, arm severely sore at injection site, chills, and extreme fatigue. This lasted for approximately 24 hours.
Patient describes that she started experiencing redness, rash, tingling, and heat on the upper part of her body (including neck, arms, hands, and face). It happens around once weekly and lasts for a few minutes. It started about a week after her vaccination. She stated that with each episode, the intensity and severity progressively get worse. It does not affect her heart rate or breathing in any way. She has called and left a message with her primary care doctor's office.
Syringe came apart in the administrator's hand as he was injecting my left arm. Some vaccine ran down my arm and was lost. The paramedic administering the injection told me "this happens all the time" and that I "only need a quarter of it (the dose)." I don't know how much vaccine I actually got and am concerned I didn't get a proper second dose.   County  Health Department referred me to the CDC. The CDC referred me to VAERS.  I need *somebody* to take ownership and tell me what to do.
Very little reaction; This case was reported by a consumer and described the occurrence of adverse event in a 54-year-old patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingrix. On an unknown date, less than 3 months after receiving Shingrix, the patient experienced adverse event. On an unknown date, the outcome of the adverse event was unknown.   It was unknown if the reporter considered the adverse event to be related to Shingrix.  Additional information received were as follows: The age at vaccination was not reported. The patient refused to provide patient's information. The patient received 1st dose of Shingrix 3 months spacing. The patient experienced very little reaction. For tolerance to 2nd dose, refer linked case US2019AMR178052.
FEELS HORRIBLE; FACE AND EARS FEEL LIKE THEY ARE ON FIRE; SKIN SENSITIVITY; OTIS MEDIA OF LEFT EAR; ELEVATED BLOOD PRESSURE; TINNITUS/RINGING OF EARS; NUMBNESS; TINGLING OF EARS AND FACE/RINGING OF FACE; NAUSEA; DIARRHEA; HEADACHE; This spontaneous report received from a consumer concerned a female of unspecified age. The patient's height, and weight were not reported. The patient's concurrent conditions included: hypertension, asthma, sinusitis, and sting bee allergy, and other pre-existing medical conditions included: The patient is sensitive to non-sedating antihistamines. The patient was not taking any inhaler or medications. The patient had no known sources of allergy before/or immediately after immunization. The patient experienced rash, skin sensitivity and swollen arm when treated with influenza vaccine for prophylactic vaccination. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin, and batch number were not reported) dose was not reported, administered on 24-MAR-2021 for prophylactic vaccination. The batch number was not reported. The company is unable to perform follow-up to request batch/lot number. Concomitant medications included valsartan for hypertension. On MAR-2021, the patient experienced nausea, diarrhea, and headache. On 24-MAR-2021, the patient experienced elevated blood pressure, tinnitus/ringing of ears, numbness, and tingling of ears and face/ringing of face. On MAR-2022, Laboratory data included: Blood pressure (NR: not provided) elevated. On an unspecified date, the patient experienced otis media of left ear, feels horrible, face and ears feel like they are on fire, and skin sensitivity. Treatment medications (dates unspecified) included: epinephrine, ibuprofen, triamcinolone acetonide, paracetamol, and diphenhydramine hydrochloride. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from elevated blood pressure, and numbness on 24-MAR-2021, had not recovered from tinnitus/ringing of ears, tingling of ears and face/ringing of face, nausea, diarrhea, headache, and feels horrible, and the outcome of face and ears feel like they are on fire, otis media of left ear and skin sensitivity was not reported. This report was non-serious.
At the time of vaccinating the patient indicates that he feels dizzy. Vasovagal protocol is started with the paramedic, HN and RVs. The whole situation occurs after vaccinating the patient and he himself feels dizzy.
Had nausea, body aches, chills and slight aches at injection site.  Some diarrhea as well. Symptoms lasted for a few hours (except diarrhea which lasted a couple of days).  All fine currently.
This case was reported by a physician and described the occurrence of multiple sclerosis relapse in a 38-year-old female subject who was vaccinated with ENGERIX B (GlaxoSmithKline). Previous vaccination included 1st and 2nd doses ENGERIX B; GlaxoSmithKline given on July 2009 and an unspecified date. On an unspecified date in January 2010 the subject received 3rd dose of ENGERIX B (20 mcg, unknown route). On an unknown date, at an unspecified time after vaccination with ENGERIX B, the subject experienced multiple sclerosis relapse. The subject also experienced numbness in January 2010, blurred vision and anisocoria in April 2010, and mri brain abnormal in May 2010. This case was assessed as medically serious by GSK. At the time of reporting the events of numbness, blurred vision and anisocoria were resolved, abnormal was unresolved, and the outcome of the multiple sclerosis relapse was unspecified. The physician suspected multiple sclerosis relapse.
CHIPPED BACK MOLAR; VOMITING; BODY ACHES; CHILLS/ HARD TEETH CHATTERING; SICKER THAN EVER BEEN AFTER SIX HOURS; NAUSEA; FEVER; This spontaneous report received from a patient via a company representative concerned a female of unspecified age. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported.The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose was not reported, administered on MAR-2021 for prophylactic vaccination. The batch number was not reported. Per procedure, no follow-up will be requested for this case. No concomitant medications were reported. On MAR-2021, the subject experienced chipped back molar. On MAR-2021, the subject experienced vomiting. On MAR-2021, the subject experienced body aches. On MAR-2021, the subject experienced chills/ hard teeth chattering. On MAR-2021, the subject experienced sicker than ever been after six hours. On MAR-2021, the subject experienced nausea. On MAR-2021, the subject experienced fever. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the sicker than ever been after six hours, fever, chills/ hard teeth chattering, nausea, body aches, vomiting and chipped back molar was not reported. This report was non-serious.
Patient received COVID vaccine (RD) at 0846, shortly after (less than 1 min) patient reports "warmness and tingling" radiating from right arm to right side of abdomen. No VS recorded, patient denied offer to take vitals. Patient sat with this RN fort 1 minute longer for observation, stated she could walk herself to observation area.
Case number PHEH2016US001422, is an initial spontaneous report from health care professional received on 13 Jan 2016. This report refers to a 33 years old male patient. Medical history and concomitant medications were not reported. The patient was administered FLUVIRIN PFS (batch number: 15722P) that was out of temperature range of 31.1 Fahrenheit for 1 hour and 30 minutes on 12 Jan 2016. No adverse event was reported.
Pain across lower back, not sore or painful to touch, not spine Woke up with the pain and it lased through out the day, sitting was more uncomfortable than standing Tender on right side of neck and at the injection sight
pain on kidney; This is a spontaneous report from a contactable consumer, the patient. A female patient of an unspecified age received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, solution for injection, lot number: unknown), dose 1 via an unspecified route of administration on an unspecified date as dose 1, single for covid-19 immunization. The patient medical history and concomitant medications were not reported. The patient had first Pfizer dose on 10th. On an unknown date, the patient experienced the pain on kidney but stated that it was not related to the vaccine. The patient was asked for percentage of swelling. The outcome of the event was unknown.  Follow-up attempts were completed. No further information was expected.
Client had no reaction to vaccines.  Hep B was inadvertently given on day 51 instead of day 52 to be within grace period of 4 day window,
Patient seen for 4 month well child check on 4/11/2007.  Normal exam.  Received routine vaccines.  That evening, patient noted to be fussy.  Improved by 10pm.  Placed face down in parents bed.  Mother awoke at 5am to find infant hot, unresponsive.  Called EMS.  Patient unable to be resuscitated and expired.  7/31/07 Received autopsy report which states COD as undetermined & manner of death as undetermined.  Patient found unresponsive in prone position while co-sleeping w/parents in adult bed.  Temp in ER was 103.2.  No congenital anomalies or traumatic injuries found at autopsy. Tox & metabolic tests were neg.  Cultures were non contributory.
Information has been received from a nurse concerning a 20 year old female patient who was vaccinated with the first and second doses of GARDASIL on 16-MAR-2009 and 26-MAY-2009 respectively. The nurse reported that when the patient was due for the third dose, the patient mentioned that "soon after she received the second dose of GARDASIL", on 26-MAY-2009, she developed rashes on her legs. The nurse also reported that the patient also developed discoloration on the top of her feet, around her ankles and the area behind her knees for both of her legs. The nurse decided not to give the third of GARDASIL dose to the patient until she saw her dermatologist. On 14-OCT-2009, the patient was seen by her dermatologist and a biopsy was performed (results not provided). The dermatologist prescribed LIDEX cream. At the time of the report, the patient's status was unknown. Follow-up information has been received from the licensed practical nurse regarding the 20 year old female patient with asthma and a history of chickenpox who was intramuscularly vaccinated with the first (Lot#660616/0570X) in the left deltoid and second (Lot#658271/0558X) in the right deltoid doses of GARDASIL on 16-MAR-2009 and 26-MAY-2009 respectively. The licensed practical nurse reported that the patient had a rash that developed on back and lower extremities after received the GARDASIL. Then the rash had been gradually worsening. Initially the rash itched but it had lessened. The patient was referred to dermatology. A biopsy was performed - results not available. The patient was diagnosed with postinflammatory hyperpigmentation. A complete blood cell count (CBC) and complete metabolic panel (CMP) were performed on 01-OCT-2009. All results were within normal limits. There was no illness at the time of vaccination. The patient's outcome was unknown. Additional information has been requested.
Within a few hours I felt a soreness or tightness it felt like in both hamstrings at the same time. Comes and goes but getting a bit worse it seems. Been over 4 weeks now since the first vaccine. Going to see my primary care doctor on Monday the 1st to discuss 2nd shot, which is the 2nd of March. Did not do anything physical on that day and have only done daily walks since.
no adverse reactions reported. patient received 2 flu shots within a month of each other even though it was verified with the patient multiple times that he was receiving a flu shot . then after receiving the flu shot that was verified with him, he said that he wanted a pnemonia shot
Both of us feel pretty bad for 3days; This is a spontaneous report from a contactable consumer (patient). A female patient of unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Solution for injection, Lot Number: EW0217, NDC number and Expiration date: Unknown), via an unspecified route of administration, administered on Arm left on 23Jun2021 as DOSE NUMBER UNKNOWN, SINGLE for COVID-19 immunisation. Medical history and concomitant medication were not reported. The patient reported as both of us feel pretty bad for 3 days on an unspecified date in Jun2021. Treatment medication included Tylenol. Outcome of the event was recovered on an unspecified date in Jun2021.
Episodes of diarrhea starting approximately 4 hours after injection, and lasting through 01/09/2021.
pt hard to sleep because of pain; redness & swelling around 8 hrs p/vax; about 1" from inject site; rash started later 2 1/2 to 2" wide; 2nd day itching;
TOOK TWO DOSES ON CONSECUTIVE DAYS; This spontaneous case (PVX2019-1307) was received from a consumer on 23-May-2019. It describes a male consumer who "took two doses on consecutive days". The consumer was receiving oral Vivotif (one dose every other day) for typhoid fever prophylaxis.  Case report: The consumer took first two doses of Vivotif on consecutive days. The doses were taken on 20-May-2019 and 21-May-2019, respectively.   Action taken with Vivotif was not applicable.  The clinical outcome of the event was unknown.  Company's Comment: The causality of the event "took two doses on consecutive days" was considered as not applicable.; Sender's Comments: Company's Comment: The causality of the event "took two doses on consecutive days" was considered as not applicable.